Abstract A163: Development of Grb2 SH3 domain antagonists
Year: 2009
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: National Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2043201351
